Preventing Severe COVID-19 with Tixagevimab-Cilgavimab in Hematological Patients Treated with Anti-CD20 Monoclonal Antibodies: An International Multicenter Study.
Saved in:
| Title: | Preventing Severe COVID-19 with Tixagevimab-Cilgavimab in Hematological Patients Treated with Anti-CD20 Monoclonal Antibodies: An International Multicenter Study. |
|---|---|
| Authors: | Azuly H; Infectious Diseases Institute, Soroka University Medical Center, and the Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel., Shafat T; Infectious Diseases Institute, Soroka University Medical Center, and the Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.; Clinical Research Center, Soroka University Medical Center and the Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Grupel D; Department of Clinical Microbiology and Infectious Diseases, Hadassah Medical Center, Jerusalem, Israel.; Faculty of Medicine, Hebrew University, Jerusalem, Israel., Porges T; Hematology Department, Soroka University Medical Center, Beer-Sheva, Israel.; Faculty of Medicine, Hebrew University, Jerusalem, Israel., Abuhasira R; Clinical Research Center, Soroka University Medical Center and the Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel., Belkin A; Internal Medicine D and Infectious Diseases Unit, Sheba Medical Center, Ramat-Gan, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Ramat-Aviv, Israel., Deri O; Internal Medicine T, Sheba Medical Center, Ramat-Gan, Israel., Oster Y; Department of Clinical Microbiology and Infectious Diseases, Hadassah Medical Center, Jerusalem, Israel.; Faculty of Medicine, Hebrew University, Jerusalem, Israel., Zahran S; Department of Clinical Microbiology and Infectious Diseases, Hadassah Medical Center, Jerusalem, Israel.; Faculty of Medicine, Hebrew University, Jerusalem, Israel., Horwitz E; Department of Clinical Microbiology and Infectious Diseases, Hadassah Medical Center, Jerusalem, Israel.; Faculty of Medicine, Hebrew University, Jerusalem, Israel., Horowitz NA; Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel., Khatib H; Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel., Batista MV; Department of Infectious Diseases, AC Camargo Cancer Center, São Paulo, SP, Brazil., Cortez AC; Department of Hematology and Cell Therapy, AC Camargo Cancer Center, São Paulo, SP, Brazil., Brosh-Nissimov T; Infectious Diseases Unit, Samson Assuta Ashdod University Hospital, Ashdod, Israel.; The Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel., Segman Y; Hematology Institute, Samson Assuta Ashdod University Hospital, Ashdod, Israel.; The Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel., Ishay L; Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, 3109601, Haifa, Israel.; Infectious Diseases Unit Hillel-Yaffe Medical Center, Hadera, Israel., Cohen R; Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, 3109601, Haifa, Israel.; Infectious Diseases Unit Hillel-Yaffe Medical Center, Hadera, Israel., Atamna A; Infectious Diseases Unit, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel., Spallone A; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Chemaly RF; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ramos JC; Infectious Disease Unit, Internal Medicine Service, CIBERINFEC. Hospital Universitario La Paz, Madrid, Spain., Chowers M; Meir Medical Centre, Kfar Saba, Israel.; Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel., Rogozin E; Infectious Diseases Unit, Shamir (Assaf Harofeh) Medical Center, Be'er Ya'akov, Israel., Oren NC; Infectious Diseases Unit, Shamir (Assaf Harofeh) Medical Center, Be'er Ya'akov, Israel., Keske Ş; Department of Infectious Diseases, VKV American Hospital, Koç University İşbank Center for Infectious Diseases (KUISCID), Istanbul, Turkey., Barchad OW; Infectious Disease Unit, Shaare Zedek Medical Center, Jerusalem, Israel., Nesher L; Infectious Diseases Institute, Soroka University Medical Center, and the Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel. nesherke@bgu.ac.il. |
| Corporate Authors: | European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Respiratory Viruses (ESGREV) |
| Source: | Infectious diseases and therapy [Infect Dis Ther] 2025 Jan; Vol. 14 (1), pp. 167-180. Date of Electronic Publication: 2024 Dec 09. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Adis Country of Publication: New Zealand NLM ID: 101634499 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2193-8229 (Print) Linking ISSN: 21936382 NLM ISO Abbreviation: Infect Dis Ther Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2193-8229 |
|---|---|
| DOI: | 10.1007/s40121-024-01089-9 |
